胃癌免疫治疗的新进展

被引：6

作者：

叶颖江

王杉

机构：

[1] 北京大学人民医院胃肠外科

来源：

中华消化外科杂志 | 2010年 / 04期

关键词：

胃肿瘤; 免疫治疗;

D O I：

暂无

中图分类号：

R735.2 [胃肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>胃癌是世界范围内重要的致死疾病之一,在全球新发癌症中占第2位。外科手术仍然是胃癌患者首选的治疗方案。尽管近年来外科手术在不断发展,但其总体5年生存率仅为15%～35%。虽然手术结合新辅助治疗和术后辅助治疗可提高少部分Ⅱ、Ⅲ期胃癌患者的生存率,但胃癌患者总体疗效始终不容乐观。各种治疗手段都有一定的特点和局限性,单独依靠某一种治疗方法很难取得理想的效果。

引用

收藏

相关论文

共 8 条

[1]

4-1BB (CD137) Ligand Enhanced Anti-Tumor Immune Response against Mouse Forestomach Carcinoma In Vivo [J].

Li, Qiaoxia ;

Ai, Jun ;

Song, Zhenchuan ;

Liu, Jie ;

Shan, Baoen .

CELLULAR & MOLECULAR IMMUNOLOGY, 2008, 5 (05) :379-384

[2]

Helicobacter pylori vaccine:: From past to future [J].

Agarwal, Kanishtha ;

Agarwal, Shvetank .

MAYO CLINIC PROCEEDINGS, 2008, 83 (02) :169-175

[3]

Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori [J].

Morihara, Fumiko ;

Hifumi, Emi ;

Yamada, Manabu ;

Nishizono, Akira ;

Uda, Taizo .

BIOTECHNOLOGY AND BIOENGINEERING, 2008, 100 (04) :634-643

[4]

Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis [J].

Cesana, Giovanni Carlo ;

Romano, Fabrizio ;

Piacentini, Gaia ;

Scotti, Marco ;

Brenna, Ambrogio ;

Bovo, Giorgio ;

Vaghi, Massimo ;

Aletti, Giacomo ;

Caprotti, Roberto ;

Kaufman, Howard ;

Uggeri, Franco .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) :1295-1304

[5]

Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer [J].

Popiela T. ;

Kulig J. ;

Czupryna A. ;

Szczepanik A.M. ;

Zembala M. .

Gastric Cancer, 2004, 7 (4) :240-245

[6]

Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients [J].

Romano, F ;

Cesana, G ;

Berselli, M ;

Piacentini, MG ;

Caprotti, R ;

Bovo, G ;

Uggeri, F .

JOURNAL OF SURGICAL ONCOLOGY, 2004, 88 (04) :240-247

[7]

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment [J].

Yamaguchi, Y ;

Ohshita, A ;

Kawabuchi, Y ;

Hihara, J ;

Miyahara, E ;

Noma, K ;

Toge, T .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (04) :959-966

[8]

Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma [J].

Homma, S ;

Matai, K ;

Irie, M ;

Ohno, T ;

Kufe, D ;

Toda, G .

JOURNAL OF GASTROENTEROLOGY, 2003, 38 (10) :989-994